Found: 23
Select item for more details and to access through your institution.
Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF/VEGFR2 signaling.
- Published in:
- 2019
- By:
- Publication type:
- journal article
D,L-Methadone does not improve radio- and chemotherapy in glioblastoma in vitro.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse model.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Apatinib for chemotherapy-refractory extensive-stage SCLC: a retrospective study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2019, v. 83, n. 6, p. 1083, doi. 10.1007/s00280-019-03823-4
- By:
- Publication type:
- Article
Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of two different carboplatin and weekly paclitaxel schedule in elderly advanced non-small cell lung cancer patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agents.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
FLAG vs FLAG-IDA: outcomes in relapsed/refractory acute leukemias.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Short-time use of crizotinib as neoadjuvant in ALK-positive non-small cell lung carcinoma can be a chance for resectability.
- Published in:
- 2019
- By:
- Publication type:
- case study
Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody-drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII.
- Published in:
- 2019
- By:
- Publication type:
- journal article